EQ
EQ
NASDAQ · Biotechnology

Equillium Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.75
-0.13 (-6.91%)
As of Mar 30, 10:09 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +1,440.6% upside
Low Target $18.17
Average Target $26.96
High Target $35.46
Current Price $1.75
Current
$1.75
Target
$26.96
$18.17 $26.96 avg $35.46
Scenario Analysis
Bear Case
$18.17
938.3%
Low target
Base Case
$26.96
+1,440.6%
Avg target
Bull Case
$35.46
+1,926.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.70
-35.2% from high
52-Week Low
$0.27
+548.1% from low
Target vs 52W High
$26.96
+898.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
 Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -29.7%